Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Secondary Prevention in Antiphospholipid Syndrome
NCT02295475Phase 4Completed
- Start
- Dec 2014
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in antiphospholipid syndrome (APS). Started Dec 2014; status: completed.
02
Drugs
apixaban
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT02295475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02295475.